Annual Current Ratio
1.28
-0.42-24.71%
December 1, 2023
Summary
- As of February 7, 2025, RNAZ annual current ratio is 1.28, with the most recent change of -0.42 (-24.71%) on December 1, 2023.
- During the last 3 years, RNAZ annual current ratio has fallen by -0.77 (-37.56%).
- RNAZ annual current ratio is now -85.73% below its all-time high of 8.97, reached on December 31, 2021.
Performance
RNAZ Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Ratio
1.58
+0.33+26.40%
September 1, 2024
Summary
- As of February 7, 2025, RNAZ quarterly current ratio is 1.58, with the most recent change of +0.33 (+26.40%) on September 1, 2024.
- Over the past year, RNAZ quarterly current ratio has dropped by -0.09 (-5.39%).
- RNAZ quarterly current ratio is now -86.18% below its all-time high of 11.43, reached on September 30, 2021.
Performance
RNAZ Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Ratio Formula
Current Ratio = Current Assets
Current Liabilities
Current Assets
Current Liabilities
Current Liabilities
RNAZ Current Ratio Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.7% | -5.4% |
| 3 y3 years | -37.6% | -86.2% |
| 5 y5 years | -60.6% | - |
RNAZ Current Ratio Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -85.7% | at low | -84.3% | +97.5% |
| 5 y | 5-year | -85.7% | at low | -86.2% | +351.4% |
| alltime | all time | -85.7% | at low | -86.2% | +351.4% |
TransCode Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 1.58(+26.4%) |
| Jun 2024 | - | 1.25(-49.6%) |
| Mar 2024 | - | 2.48(+93.8%) |
| Dec 2023 | 1.28(-24.7%) | 1.28(-23.4%) |
| Sep 2023 | - | 1.67(+20.1%) |
| Jun 2023 | - | 1.39(+73.8%) |
| Mar 2023 | - | 0.80(-52.9%) |
| Dec 2022 | 1.70 | 1.70(-44.6%) |
| Sep 2022 | - | 3.07(-61.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | 8.06(-20.0%) |
| Mar 2022 | - | 10.08(+12.4%) |
| Dec 2021 | 8.97(+337.6%) | 8.97(-21.5%) |
| Sep 2021 | - | 11.43(+3165.7%) |
| Jun 2021 | - | 0.35(-52.1%) |
| Mar 2021 | - | 0.73(-64.4%) |
| Dec 2020 | 2.05(-36.9%) | - |
| Dec 2020 | - | 2.05 |
| Dec 2019 | 3.25 | - |
FAQ
- What is TransCode Therapeutics annual current ratio?
- What is the all time high annual current ratio for TransCode Therapeutics?
- What is TransCode Therapeutics annual current ratio year-on-year change?
- What is TransCode Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly current ratio year-on-year change?
What is TransCode Therapeutics annual current ratio?
The current annual current ratio of RNAZ is 1.28
What is the all time high annual current ratio for TransCode Therapeutics?
TransCode Therapeutics all-time high annual current ratio is 8.97
What is TransCode Therapeutics annual current ratio year-on-year change?
Over the past year, RNAZ annual current ratio has changed by -0.42 (-24.71%)
What is TransCode Therapeutics quarterly current ratio?
The current quarterly current ratio of RNAZ is 1.58
What is the all time high quarterly current ratio for TransCode Therapeutics?
TransCode Therapeutics all-time high quarterly current ratio is 11.43
What is TransCode Therapeutics quarterly current ratio year-on-year change?
Over the past year, RNAZ quarterly current ratio has changed by -0.09 (-5.39%)